Predictors of Clinical Course and Treatment Response in DBT Programmes

Recruiting N/A Interventional Study
Self Harm Borderline Personality Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 70
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
250 (estimated)
Sponsor
Oslo University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The project is a collaboration between The National Centre for Suicide Research and Prevention (NSSF) and clinical units with Dialectical Behaviour Therapy (DBT) programmes. A methodological and technological platform has been established that enables clinicians to deliver high quality treatments over extended periods of time, to evaluate their own performance and productivity and to report it in …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * History of repeated deliberate self harm * Satisfies criteria of Diagnostic and Statistical Manual (DSM-IV) Borderline Personality Disorder as measured by Structured Clinical Interview for the DSM (SCID-II) in addition to the self-destructive criterion. Exclusion Criteria: *…
Contacts

Egil Haga, PhD

+4722923442

egil.haga@medisin.uio.no

CONTACT

Lars Mehlum, MD PhD

+4722923442

lars.mehlum@medisin.uio.no

CONTACT